logo

NRSN

NeuroSense·NASDAQ
--
--(--)
--
--(--)
2.86 / 10
Underperform

NeuroSense's fundamentals score just 2.9/10. Key concerns include negative asset and revenue momentum (Asset-MV and Revenue-MV in lower quartiles) and a high PB-ROE of 25.9386, signaling valuation risk. While cash flow and profit metrics show some resilience, the overall picture remains underperform, warranting caution.

Fundamental(2.86)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.19
Score1/3
Weight13.04%
1M Return5.20%
Inventory turnover ratio
Value37.99
Score3/3
Weight11.46%
1M Return5.26%
Gross profit margin (%)
Value38.10
Score1/3
Weight-1.01%
1M Return-0.54%
Profit-MV
Value-0.06
Score2/3
Weight19.52%
1M Return7.79%
PB-ROE
Value25.94
Score2/3
Weight27.40%
1M Return10.68%
Current assets turnover ratio
Value1.17
Score2/3
Weight2.28%
1M Return1.15%
Fixed assets turnover ratio
Value1031.01
Score3/3
Weight1.66%
1M Return0.86%
Asset-MV
Value-4.24
Score0/3
Weight6.67%
1M Return2.94%
Cash-MV
Value-0.14
Score2/3
Weight19.55%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.58%
1M Return-0.30%
Is NRSN undervalued or overvalued?
  • NRSN scores 2.86/10 on fundamentals and holds a Premium valuation at present. Backed by its -456.30% ROE, 0.00% net margin, -3.59 P/E ratio, -59.97 P/B ratio, and 35.71% earnings growth, these metrics solidify its Underperform investment rating.